Clinical Trials Directory

Trials / Terminated

TerminatedNCT02858245

A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device

A Feasibility Registry on Use of Actigraphy Monitoring in Degenerative Mitral Regurgitation (DMR) Subjects Receiving the MitraClip® Device

Status
Terminated
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective, open-label, and multi-centered feasibility registry.

Detailed description

This is a prospective, open-label, and multi-centered feasibility registry (single arm study). Approximately 36 subjects with prohibitive risk degenerative mitral regurgitation (DMR) who receive at least 1 commercial MitraClip will be registered at up to 10 US sites.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention - registry

Timeline

Start date
2016-11-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2016-08-08
Last updated
2018-05-07

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02858245. Inclusion in this directory is not an endorsement.